Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1130

Lactobacillus rhamnosus CGMCC21225

Intended Use: Intended for use as an ingredient at a maximum level of 1 x 109 CFU/serving in energy and sports drinks; flavored, carbonated, enhanced and fortified waters; meal replacement, protein, and nutritional drinks; bottled tea; processed fruits and fruit juices; breakfast cereals; cheeses; chewing gum; buttermilk; plain fermented milks; flavored milks, milk drinks, and mixes; milk shakes; evaporated and condensed milks; yogurt and yogurt drinks; milk-based gelatins, puddings, and filings; soy-based drinks and other soy-based products; bars; soft and hard candies; and foods intended for infants (cereals, fruits, vegetables, and fruit juices).
Basis: Scientific procedures
Notifier: Glac Biotech Co., Ltd.
Notifier Address: 3F-2, No. 17, Guoji Rd.
Xinshi Dist., Tainan City 74442
Taiwan
GRAS Notice (releasable information): GRN 1130 with amendments (in PDF) (10.1 MB)
Date of closure: Sep 28, 2023
FDA's Letter: FDA has no questions (in PDF) (248 kB)
-
-